Clearmind Medicine CMND
NASDAQ CMND
$5.99 -0.13 (-2.04%)
As of: Oct 21, 2026 · 3:52 PM EDT

Clearmind Medicine (CMND) Interest Expenses (2022 - 2023)

Updated

Clearmind Medicine (CMND) posted Interest Expenses of -$190,708 for fiscal Q1 2026 (quarter ended Jan 31, 2026), compared with $463,888 a year earlier.

Analysis

Clearmind Medicine (CMND) Interest Expenses (2022 - 2023) Analysis & Trends

For the trailing twelve months through Jan 31, 2026, Interest Expenses at Clearmind Medicine was $1.15 million, up 2.9% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $1.88 million, up 116.6% from FY2024.

  • In prior fiscal years, Clearmind Medicine's Interest Expenses was $868,213 in FY2024, -$2.32 million in FY2023, -$15,299 in FY2022 and -$26,663 in FY2021.
  • The fiscal Q1 2026 figure stands as the lowest quarterly Interest Expenses since fiscal Q3 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Clearmind Medicine 9,526.05 -39.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2023 -3,707.71
Apr 30, 2022 -83,018.56
Jan 31, 2022 -5,107.09
API Access

Clearmind Medicine Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=CMND&period=max&api_key=YOUR_API_KEY